Tadalista is a brand name for tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). The original formulation of tadalafil was first approved by the U.S. Food and Drug Administration (FDA) on November 21, 2003, under the brand name Cialis, developed by Eli Lilly and Company.
Tadalista, as a generic version of tadalafil, was introduced after the patent for Cialis expired, allowing other pharmaceutical companies to produce and market tadalafil under different brand names. The exact approval date for Tadalista may vary depending on the manufacturer and the country in which it was approved. For instance, Glenmark Pharmaceuticals received final approval from the FDA for its generic tadalafil tablets on December 31, 2020.
Add your comment